2012 -- H 7834 SUBSTITUTE A AS AMENDED | |
======= | |
LC01668/SUB A | |
======= | |
STATE OF RHODE ISLAND | |
| |
IN GENERAL ASSEMBLY | |
| |
JANUARY SESSION, A.D. 2012 | |
| |
____________ | |
| |
A N A C T | |
RELATING TO HEALTH AND SAFETY - - THE RHODE ISLAND LUPUS EDUCATION | |
AND AWARENESS PLAN | |
|
      |
|
      |
     Introduced By: Representatives Diaz, Naughton, Ferri, Tanzi, and Slater | |
     Date Introduced: February 28, 2012 | |
     Referred To: House Health, Education & Welfare | |
It is enacted by the General Assembly as follows: | |
1-1 |
     SECTION 1. Title 23 of the General Laws entitled "HEALTH AND SAFETY" is hereby |
1-2 |
amended by adding thereto the following chapter: |
1-3 |
     CHAPTER 87 |
1-4 |
THE RHODE ISLAND LUPUS EDUCATION AND AWARENESS PLAN |
1-5 |
     23-87-1. Short title. -- This chapter shall be known and maybe cited as the “Rhode |
1-6 |
Island Lupus Education and Awareness Plan Act of 2012.” |
1-7 |
     23-87-2. Legislative findings. -- It is hereby found and declared as follows: |
1-8 |
     (1) Lupus is an urgent national health issue. Lupus is the result of an immune system that |
1-9 |
is unbalanced which can become destructive to any organ or tissue in the body. Lupus is |
1-10 |
unpredictable and potentially fatal, yet no satisfactory treatment exists. Its health consequences |
1-11 |
include heart attacks, strokes, seizures, and organ failure. |
1-12 |
     (2) The Lupus Foundation of America, Inc. estimates that more than 1.5 million |
1-13 |
Americans live with some form of lupus, including an estimated five thousand two hundred |
1-14 |
(5,200) people with lupus in Rhode Island. |
1-15 |
     23-87-3. Purpose. – The purpose of this chapter is to create a study commission which |
1-16 |
will develop a multi-pronged, statewide plan to educate healthcare professionals and persons |
1-17 |
affected with lupus about the diagnosis, management, and treatment of lupus. |
1-18 |
     23-87-4. Establishment of the lupus study commission. -- (a) The director of the |
1-19 |
department of health shall establish and coordinate a study commission on lupus consisting of |
2-1 |
nine (9) members, all of whom shall be appointed by the director of the department of health. The |
2-2 |
first chairperson shall be a representative of the Lupus Foundation of America, Inc. and shall |
2-3 |
serve for a two (2) year term. Subsequent chairpersons shall be elected by the membership of the |
2-4 |
study commission from among its members. |
2-5 |
     (b) The commission shall be composed of: |
2-6 |
     (1) Two (2) individuals with lupus; |
2-7 |
     (2) One scientist with experience in lupus and who participates in various fields of |
2-8 |
scientific endeavor, including, but not limited to, biomedical research, social, translational, |
2-9 |
behavioral or epidemiological research recommended by the medical and scientific council of the |
2-10 |
Lupus Foundation of America, Inc; |
2-11 |
     (3) Two (2) physicians with experience in treating people with lupus and recommended |
2-12 |
by the Rhode Island medical society; |
2-13 |
     (4) One nurse practitioner with experience in treating people with lupus and |
2-14 |
recommended by the Rhode Island nurse practitioners’ council; |
2-15 |
     (5) One local representative from the Lupus Foundation of America, Inc.; |
2-16 |
     (6) One representative recommended by the department of health’s minority health |
2-17 |
advisory committee; and |
2-18 |
     (7) One representative recommended by the women’s health council of Rhode Island. |
2-19 |
     (c) All appointments to the study commission shall be made not later than sixty (60) days |
2-20 |
after the effective date of this chapter. Members of the commission shall serve terms of two (2) |
2-21 |
years. A member may be appointed to serve not more than two (2) terms, whether or not |
2-22 |
consecutive. |
2-23 |
     (d) The commission shall meet at the call of the chair and no less than on a quarterly |
2-24 |
basis each year. |
2-25 |
     (e) Five (5) members of the study commission shall constitute a quorum. A majority vote |
2-26 |
of a quorum shall be required for any official action of the study commission. |
2-27 |
     23-87-5. Establishment of the lupus education and awareness plan (LEAP). -- (a) |
2-28 |
The study commission established in this chapter shall: |
2-29 |
     (1) Analyze the current state of education on lupus in the state; |
2-30 |
     (2) Evaluate materials and resources currently available from government agencies, |
2-31 |
hospitals, lupus advocacy organizations; and |
2-32 |
     (3) Identify gaps in the current lupus education modalities in the state through a needs |
2-33 |
assessment or similar mechanism. |
3-34 |
     (b) Upon completing the needs assessment described in subsection (a), the study |
3-35 |
commission shall report on the results of its assessment to the department of health and to the |
3-36 |
general assembly. Utilizing the results of such assessment, and with input from the committees of |
3-37 |
the general assembly, having cognizance of matters relating to public heath and the department of |
3-38 |
health, the study commission shall develop a comprehensive lupus education and awareness plan. |
3-39 |
     (c) The study commission shall develop a comprehensive plan to improve education and |
3-40 |
awareness surrounding lupus for healthcare practitioners, public health personnel, patients, and |
3-41 |
persons who may have lupus. The plan shall include the recommendations on how to best: |
3-42 |
     (1) Distribute medically-sound health information produced by the Lupus Foundation of |
3-43 |
America, Inc., the Lupus Foundation of New England and/or government agencies, including, but |
3-44 |
not limited to, the National Institutes of Health, the Centers for Disease Control and Prevention, |
3-45 |
and the Social Security Administration, through local health departments, schools, agencies on |
3-46 |
aging, employer wellness programs, physicians and other health professionals, hospitals, health |
3-47 |
plans and health maintenance organizations, women’s health, and nonprofit and community- |
3-48 |
based organizations; |
3-49 |
     (2) Utilize volunteers in the community to distribute brochures and other materials that |
3-50 |
promote lupus education and awareness; |
3-51 |
     (3) Develop educational materials for health professionals that identify the most recent |
3-52 |
scientific and medical information and clinical applications regarding the treatment of lupus; |
3-53 |
     (4) Work to increase knowledge among physicians, nurses, and health and human |
3-54 |
services professionals about the importance of lupus diagnosis, treatment, and rehabilitation; |
3-55 |
     (5) Support continuing medical education plans in the state’s leading academic |
3-56 |
institutions by providing them the most recent scientific and medical information and clinical |
3-57 |
applications regarding the treatment of lupus; |
3-58 |
     (6) Conduct statewide workshops and seminars for extensive professional development |
3-59 |
regarding the care and management of patients with lupus in an effort to bring the latest |
3-60 |
information on clinical advances to care providers; and |
3-61 |
     (7) Develop and maintain a directory of lupus-related healthcare services, that includes a |
3-62 |
listing of healthcare providers with specialization in services to diagnose and treat lupus and that |
3-63 |
can be disseminated, within available appropriations, by the department of health to individuals |
3-64 |
with lupus, family members of those with lupus, representatives from voluntary organizations, |
3-65 |
healthcare professionals, health plans, local health agencies and authorities and to other agencies |
3-66 |
of the state. |
3-67 |
     (d) The study commission shall report its findings and recommendations to the Rhode |
3-68 |
Island department of health and to both chambers of the general assembly annually on or before |
4-1 |
December 1, commencing in 2014. The study commission may make periodic revisions to the |
4-2 |
plan that are consistent with the purposes of this section. |
4-3 |
     SECTION 2. This act shall take effect upon passage. |
      | |
======= | |
LC01668/SUB A | |
======== | |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO HEALTH AND SAFETY - - THE RHODE ISLAND LUPUS EDUCATION | |
AND AWARENESS PLAN | |
*** | |
5-1 |
     This act would establish the “Rhode Island Lupus Education and Awareness Plan” and a |
5-2 |
lupus study commission to develop a statewide plan that would educate healthcare professionals |
5-3 |
and persons affected with lupus. The commission would report its findings and recommendations |
5-4 |
to the department of health and to the general assembly on an annual basis. |
5-5 |
     This act would take effect upon passage. |
      | |
======= | |
LC01668/SUB A | |
======= | |